Back

Intra-Cellular Therapies Stock Predictions

He cracked the code to crypto

Now he says a new two-year bull market has begun. And he likes one altcoin above all others.

Sell

ITCI
Intra-Cellular Therapies

Last Price:

72.36

Seasonality Move:

8.06%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Intra-Cellular Therapies Stock Forecast

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 27.6% based on the past 10 years of stock performance.
Intra-Cellular Therapies has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $72.04. The Score for ITCI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Intra-Cellular Therapies Stock Go Up Next Year?

Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 27.6% based on the past 10 years of stock performance.

Intra-Cellular Therapies Stock Rating

Sell

Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies overpriced?

Intra-Cellular Therapies has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Intra-Cellular Therapies Stock Price History

Is ITCI stock going to rise?

The current trend is moderately bullish and ITCI is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

intracellulartherapies.com

52-Week Data

52-Week High:

84.89

52-Week Low:

45.50

Prediction Charts

Market Cap:

6.97B

Price in USD:

72.04

Volume:

4.29M

Beta:

1.11

Technical Analysis

SMA50:

69.22

SMA100:

67.73

SMA200:

61.97

52-Wk Change:

15.47%

Stock Predictions

Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company.
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 72.04 USD today.
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-2	66.94	66.63	67.55	65.93
Apr-3	66.28	67.35	68.73	65.99
Apr-4	68.49	67.21	69.33	66.61
Apr-5	67.29	68.45	69.50	67.02
Apr-8	68.74	67.72	68.91	67.33
Apr-9	68.07	68.63	69.02	67.90
Apr-10	67.12	67.25	68.12	66.53
Apr-11	67.89	67.97	68.68	66.53
Apr-12	68.04	65.88	68.67	64.84
Apr-15	65.71	64.77	66.05	64.16
Apr-16	75.29	79.86	84.89	75.00
Apr-17	79.00	76.69	83.25	76.50
Apr-18	74.40	72.04	75.08	71.21
Apr-19	72.31	72.37	74.56	70.93

Intra-Cellular Therapies Earnings

Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.

Intra-Cellular Therapies Forecast Revenue Growth

Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.94 per share, and an increase next year of $1.61 per share.

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.